arrow
J

Jonathon B. Cohen

Emory University
H指数:44
被引数:8,932

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy

滤泡性淋巴瘤接受免疫化疗的治疗诊断至治疗间隔与结局相关

Blood
IF23.1
2026-04-160
PRE
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma

伊匹木单抗、纳武利尤单抗和 Brentuximab Vedotin 治疗复发霍奇金淋巴瘤的随机二期研究

Blood
IF23.1
2026-04-011
PRE
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study
2025-11-010
PRE
Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma- Results from the ABC Consortium

大B细胞淋巴瘤在CAR T细胞治疗失败后使用双特异性抗体的疗效——ABC Consortium研究的结果

2025-10-240
OAAI
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort

自评生成的Charlson合并症指数在淋巴瘤结局流行病学(LEO)队列中的适应性和表现

2025-10-070
PRE
Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403

II期研究:将venetoclax加入bendamustine和obinutuzumab用于高风险滤泡性淋巴瘤患者的一线治疗:PrE0403

2025-05-120
OA
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study

R-gemox治疗复发或难治性弥漫性大b细胞淋巴瘤的疗效: 一项多中心队列研究

2025-02-070
PRE
Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease
2024-12-010
PRE
Vitamin D in patients with low tumor-burden indolent non- Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial
2024-12-011
OAAI
Trial in Progress- Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma

试验进行中-联盟A052101:一项关于在老年套细胞淋巴瘤患者中,作为一线治疗使用zanubrutinib进行持续与间歇维持治疗的随机III期试验

BLOOD
IF23.1
2024-11-050
PRE
Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation
2024-10-230
OAAI
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial
2024-10-032
OAAI
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation

滤泡性淋巴瘤的造血细胞移植和细胞治疗的临床实践建议: 代表美国移植和细胞治疗学会和欧洲血液和骨髓移植学会的合作努力

2024-09-012
OAAI
Defining primary refractory large B-cell lymphoma

定义原发性难治性大b细胞淋巴瘤

2024-06-261
OAAI
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
2024-05-285
OAAI
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
2024-05-166
OAAI